Your browser doesn't support javascript.
loading
Perturbation of BRMS1 interactome reveals pathways that impact metastasis.
Zimmermann, Rosalyn C; Sardiu, Mihaela E; Manton, Christa A; Miah, Md Sayem; Banks, Charles A S; Adams, Mark K; Koestler, Devin C; Hurst, Douglas R; Edmonds, Mick D; Washburn, Michael P; Welch, Danny R.
Affiliation
  • Zimmermann RC; Department of Cancer Biology, The Kansas University Medical Center, Kansas City, KS, United States of America.
  • Sardiu ME; Stowers Institute for Medical Research, Kansas City, Missouri, United States of America.
  • Manton CA; Department of Biostatistics and Data Science, The Kansas University Medical Center, Kansas City, KS, United States of America.
  • Miah MS; The University of Kansas Cancer Center, Kansas City, KS, United States of America.
  • Banks CAS; Department of Cancer Biology, The Kansas University Medical Center, Kansas City, KS, United States of America.
  • Adams MK; Pathology Department, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
  • Koestler DC; Department of Biology, Baker University, Baldwin City, KS, United States of America.
  • Hurst DR; Stowers Institute for Medical Research, Kansas City, Missouri, United States of America.
  • Edmonds MD; Department of Biochemistry and Molecular Biology, University of Arkansas for Health Sciences, Little Rock, AR, United States of America.
  • Washburn MP; Stowers Institute for Medical Research, Kansas City, Missouri, United States of America.
  • Welch DR; Stowers Institute for Medical Research, Kansas City, Missouri, United States of America.
PLoS One ; 16(11): e0259128, 2021.
Article in En | MEDLINE | ID: mdl-34788285
ABSTRACT
Breast Cancer Metastasis Suppressor 1 (BRMS1) expression is associated with longer patient survival in multiple cancer types. Understanding BRMS1 functionality will provide insights into both mechanism of action and will enhance potential therapeutic development. In this study, we confirmed that the C-terminus of BRMS1 is critical for metastasis suppression and hypothesized that critical protein interactions in this region would explain its function. Phosphorylation status at S237 regulates BRMS1 protein interactions related to a variety of biological processes, phenotypes [cell cycle (e.g., CDKN2A), DNA repair (e.g., BRCA1)], and metastasis [(e.g., TCF2 and POLE2)]. Presence of S237 also directly decreased MDA-MB-231 breast carcinoma migration in vitro and metastases in vivo. The results add significantly to our understanding of how BRMS1 interactions with Sin3/HDAC complexes regulate metastasis and expand insights into BRMS1's molecular role, as they demonstrate BRMS1 C-terminus involvement in distinct protein-protein interactions.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Limits: Humans Language: En Journal: PLoS One Year: 2021 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Limits: Humans Language: En Journal: PLoS One Year: 2021 Document type: Article